Favorable safety and immunogenicity of a combined quadrivalent influenza and recombinant SARS-CoV-2 vaccine in Sprague-Dawley rats for both primary and booster immunization - Quiz - MDSpire

Safety and Immunogenic Response of a Novel Combined Quadrivalent Influenza and Recombinant SARS-CoV-2 Vaccine in Sprague-Dawley Rats During Primary and Booster Doses

  • By

  • Jinjin Shao

  • Chengda Zhang

  • Guangbiao She

  • Tian Qin

  • Jinyao Zhang

  • Minxi Fang

  • Dan Zhao

  • Linying Wang

  • Lijuan Xia

  • Qian Yang

  • Lili Zhang

  • Yanling Zhang

  • Siming Zhang

  • Jiahong Wang

  • Zhiqi Xie

  • Yunxiang Chen

  • Ying Chen

  • Enqi Huang

  • Lijiang Zhang

  • July 17, 2026

Share

Original Source(s)

Favorable safety and immunogenicity of a combined quadrivalent influenza and recombinant SARS-CoV-2 vaccine in Sprague-Dawley rats for both primary and booster immunization

  • by Jinjin Shao, Chengda Zhang, Guangbiao She, Tian Qin, Jinyao Zhang, Minxi Fang, Dan Zhao, Linying Wang, Lijuan Xia, Qian Yang, Lili Zhang, Yanling Zhang, Siming Zhang, Jiahong Wang, Zhiqi Xie, Yunxiang Chen, Ying Chen, Enqi Huang, Lijiang Zhang

  • July 17, 2026

Related Content

A single-center observational study of nirsevimab for prevention of RSV infection in preterm infants

How Pandemics Have Reshaped the Respiratory Virus Data Landscape in Europe: Scoping Review

Diagnostic performance of vascular endothelial growth factor D in severity stratification of pediatric COVID-19 and multisystem inflammatory syndrome in children